Author: Alan Brochstein, CFA
GW Pharmaceuticals (NASDAQ: GWPH) reported its fiscal year-end results today and held a conference call after the market closed. One of the more interesting parts of the prepared remarks involved...
Colorado reports a total of 508 medical marijuana centers and 408 retail stores in the state, some of which overlap, but until the opening of Simply Pure, none were...
Following a powerful keynote speech by Drug Policy Alliance Executive Director Ethan Nadelmann, attendees at the Cannabis Private Investment Summit, organized by Noa Kahner of Kahner Global, were treated...
One of the continuing challenges that new PM Justin Trudeau and his administration will need to address is the continued flagrant violation of federal laws that prohibit cannabis dispensaries....
We publish a lot of content on the Canadian cannabis industry at New Cannabis Ventures. 15% of our visitors reside in Canada, perhaps consequently, and I spend a great deal of...
Colorado-based premium marijuana infused products maker Dixie Brands has been busy lately, announcing new products as well as expansion plans in several states and Australia for its core business,...
After failing to close its previously announced transaction to sell itself to Abba Medix (CSE:ABA), RedeCan Pharm, which is licensed by Health Canada under MMPR to sell cannabis grown...
More than nine months after receiving its license to cultivate, Aurora Cannabis, which has the sole licensed facility in Alberta, has finally received approval to sell to patients according to...
This next week will be a big one for GW Pharmaceuticals (NASDAQ: GWPH). In addition to presenting at the Piper Jaffray Healthcare Conference in NYC on Wednesday, it will...
Following up on yesterday’s report that CannLabs had closed its Colorado testing lab, we note that the company has filed a brief statement with the SEC via Form 8-K: On...
We reported earlier this month that Denver, fearing saturation of the cannabis market, was contemplating extending by two years a moratorium on new licenses set to expire on January...
We are hearing that testing lab CannLabs has closed its sole facility at 3888 E. Mexico in Denver, Colorado. According to our sources, all of the employees have been...
The Florida Health Department has awarded 5 licenses for low-THC cannabis oil that is part of the state’s Compassionate Use medical marijuana program after reviewing 28 applications. The program...
I was fortunate to meet Constance Finley, CEO and Founder, Constance Therapeutics at a conference in Denver in October. Already familiar with her as a leader in the industry, my quick...
GW Pharma (GWPH) plunged today before quickly recovering some of the losses following the release of an abstract of a study published to the American Epilepsy Society website in...
Update: The company has provided the following statement subsequent to the publication of this article: Bio-Tech Medical Software, Inc. dba BioTrackTHC™, the leading provider of seed-to-sale cannabis tracking software...
Surna (OTC:SRNA), the Boulder-based cannabis technology company, saw explosive growth in its Q3, with sales of $3.6mm. While the company reported an operating and net loss, it was able...
Cannabis business accelerator CanopyBoulder is now taking applications for its next class. As it winds up its Fall program, it plans to offer two separate programs beginning in February,...
Toronto-based Mettrum Health reported Fiscal 2016 Q2 results after the close. Sales of $1.711mm for the quarter ending in September more than doubled from the same period a year...
MassRoots (OTC: MSRT) just issued a press release indicating that it has raised over $1mm. The company filed a prospectus on 11/09 after the close of trading indicating that it...
This morning, MassRoots (OTC:MSRT) shareholders learned that the SEC has allowed it to sell up to 6.2mm units consisting of shares of stock and warrants to buy additional stock....
Scotts Miracle-Gro (NYSE:SMG), the Ohio-based lawn and garden company that acquired cannabis industry supplier General Hydroponics earlier this year for $130mm, reported its 4th-quarter earnings for the year ending September...
Alan Brochstein, CFA, discussed the “State of the Legal Canadian Cannabis Industry” at the eMoneyShow Virtual Conference on 10/30/15: One of the biggest barriers to investing in cannabis companies is that...
Health Canada, which oversees Canada’s medical marijuana program, released quarterly data on 10/21 for the quarter ending 6/30. The timing was quite odd, coming just a day after the...
In a first-of-its-kind type of transaction, a U.S. publicly-traded company has acquired a Canadian licensed producer of cannabis, Hydropothecary, on the morning after the change in the government leadership that suggests the...